# BPC-157 Human Trial: 87.5% of Knee Pain Patients Report Significant Relief at 612 Months Chronic knee pain is one of the most common reasons people turn to peptide therapy
This peptide was originally isolated from human gastric juice in 1993 by Dr
Immune modulation is relevant: peptides can lower inflammation or shift immune signaling, which matters for implantation and sperm survival
FDA to Revisit BPC-157 and Other Peptides On July 2324, 2026, FDA's Pharmacy Compounding Advisory Committee will consider whether BPC-157, along with KPV, TB-500, MOTS-c, Semax, Epitalon, and Emideltide, should be included on the Section 503A Bulks List for pharmacy compounding
Higher concentrations dont have clearly better outcomes data and may cost more